Warning: The NCBI web site requires JavaScript to function. more...
Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.
Falagas ME, Kasiakou SK.
Crit Care. 2006 Feb;10(1):R27. Review.
Related citations
Colistin: the revival of polymyxins for the management of multidrug-resistant gram-negative bacterial infections.
Clin Infect Dis. 2005 May 1;40(9):1333-41. Epub 2005 Mar 22. Review. Erratum in: Clin Infect Dis. 2006 Jun 15;42(12):1819. Dosage error in article text.
Polymyxin antibiotics for gram-negative infections.
Arnold TM, Forrest GN, Messmer KJ.
Am J Health Syst Pharm. 2007 Apr 15;64(8):819-26. Review.
The use of intravenous and aerosolized polymyxins for the treatment of infections in critically ill patients: a review of the recent literature.
Falagas ME, Kasiakou SK, Tsiodras S, Michalopoulos A.
Clin Med Res. 2006 Jun;4(2):138-46. Review.
Colistin and polymyxin B in critical care.
Michalopoulos A, Falagas ME.
Crit Care Clin. 2008 Apr;24(2):377-91, x. Review.
Polymyxins: older antibiotics for a new threat.
Lee SY, Kuti JL, Nicolau DP.
Conn Med. 2006 Jan;70(1):25-8.
Intraventricular or intrathecal use of polymyxins in patients with Gram-negative meningitis: a systematic review of the available evidence.
Falagas ME, Bliziotis IA, Tam VH.
Int J Antimicrob Agents. 2007 Jan;29(1):9-25. Epub 2006 Nov 28. Review.
Polymyxin B sulfate and colistin: old antibiotics for emerging multiresistant gram-negative bacteria.
Evans ME, Feola DJ, Rapp RP.
Ann Pharmacother. 1999 Sep;33(9):960-7. Review.
New information about the polymyxin/colistin class of antibiotics.
Molina J, Cordero E, Pachón J.
Expert Opin Pharmacother. 2009 Dec;10(17):2811-28. Review.
Re-emergence of colistin in today's world of multidrug-resistant organisms: personal perspectives.
Falagas ME, Rafailidis PI.
Expert Opin Investig Drugs. 2008 Jul;17(7):973-81. Review.
[Polymyxins - review with emphasis on nephrotoxicity].
Mendes CA, Burdmann EA.
Rev Assoc Med Bras. 2009 Nov-Dec;55(6):752-9. Review. Portuguese.
Local administration of polymyxins into the respiratory tract for the prevention and treatment of pulmonary infections in patients without cystic fibrosis.
Infection. 2007 Feb;35(1):3-10. Review.
Polymyxins revisited.
Landman D, Georgescu C, Martin DA, Quale J.
Clin Microbiol Rev. 2008 Jul;21(3):449-65. Review.
Pandrug-resistant Gram-negative bacteria: the dawn of the post-antibiotic era?
Falagas ME, Bliziotis IA.
Int J Antimicrob Agents. 2007 Jun;29(6):630-6. Epub 2007 Feb 16. Review.
Polymyxin B for the treatment of multidrug-resistant pathogens: a critical review.
Zavascki AP, Goldani LZ, Li J, Nation RL.
J Antimicrob Chemother. 2007 Dec;60(6):1206-15. Epub 2007 Sep 17. Review.
Resistance in nonfermenting gram-negative bacteria: multidrug resistance to the maximum.
McGowan JE Jr.
Am J Infect Control. 2006 Jun;34(5 Suppl 1):S29-37; discussion S64-73. Review.
Polymyxins and their novel derivatives.
Vaara M.
Curr Opin Microbiol. 2010 Oct;13(5):574-81. Epub 2010 Sep 24. Review.
Old antibiotics for infections in critically ill patients.
Falagas ME, Kopterides P.
Curr Opin Crit Care. 2007 Oct;13(5):592-7. Review.
Am J Med. 2006 Jun;119(6 Suppl 1):S29-36; discussion S62-70. Review.
Role of old antibiotics in multidrug resistant bacterial infections.
Maviglia R, Nestorini R, Pennisi M.
Curr Drug Targets. 2009 Sep;10(9):895-905. Review.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on